Guieu, B.; Lecoutey, C.; Legay, R.; Davis, A.; Sopkova de Oliveira Santos, J.; Altomare, C.D.; Catto, M.; Rochais, C.; Dallemagne, P.
First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease. Molecules 2021, 26, 80.
https://doi.org/10.3390/molecules26010080
AMA Style
Guieu B, Lecoutey C, Legay R, Davis A, Sopkova de Oliveira Santos J, Altomare CD, Catto M, Rochais C, Dallemagne P.
First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease. Molecules. 2021; 26(1):80.
https://doi.org/10.3390/molecules26010080
Chicago/Turabian Style
Guieu, Benjamin, Cedric Lecoutey, Rémi Legay, Audrey Davis, Jana Sopkova de Oliveira Santos, Cosimo Damiano Altomare, Marco Catto, Christophe Rochais, and Patrick Dallemagne.
2021. "First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease" Molecules 26, no. 1: 80.
https://doi.org/10.3390/molecules26010080
APA Style
Guieu, B., Lecoutey, C., Legay, R., Davis, A., Sopkova de Oliveira Santos, J., Altomare, C. D., Catto, M., Rochais, C., & Dallemagne, P.
(2021). First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease. Molecules, 26(1), 80.
https://doi.org/10.3390/molecules26010080